info@stratacuity.com
(603) 766-0600
MYTIME Sign In
CONTACT US

View real examples of searches completed by our scientific recruiters

Our scientific recruiters have a proven track record of finding top-tier candidates for a wide range of scientific jobs in the life sciences industry. Below are a few examples of searches we have completed over the last few years.

Research & Discovery

Permanent

Vice President, CNS Gene Editing, Cambridge, MA: Mid-sized biotech developing genomic medicines
Vice President of DMPK, San Francisco, CA: Mid-sized biotech evolving medicines for oncology
Executive Director, Immunology, Framingham, MA: Startup biotech advancing novel therapies for oncology and autoimmune diseases
Senior Director, Translational Sciences, Cambridge, MA: Small biotech advancing programmable therapeutics for multiple diseases
Senior Director, Toxicology, Waltham, MA: Mid-sized clinical-stage biotech expanding therapies for antibody technologies
Senior Director, Boston, MA: Large biotech advancing synthetic biology for various therapeutic areas
Director, Protein Sciences, Cambridge, MA: Mid-sized biotech developing genomic medicines
Director, IO Development, Boston, MA: Small biotech creating immune cell therapies for treating patients with cancer and immune disorders
Director, Oncology, Cambridge, MA: Small biotech developing therapies for the treatment of cancer and other diseases
Director, Biology, Watertown, MA: Small biopharmaceutical company focused on developing therapies for hematologic disorders
Director, Immuno-Oncology, Waltham, MA: Mid-sized clinical-stage biotech expanding therapies for antibody technologies
Director, Research, London/Greater Boston, MA: Small clinical-stage biotech expanding psychedelics for medicine
Director, Immunology, Cambridge, MA: Small biotech developing therapies for the treatment of cancer and other diseases
Director, RNA & Protein Sciences, Boston, MA: Small biotech progressing ncRNA for immunology and oncology
Director, Preclinical Safety, Cambridge, MA: Small biotech improving novel approaches for genetic disorders
Director, Innovation & Exploratory Research, Cambridge, MA: Small, clinical stage company developing immunotherapy treatments utilizing T cell therapies for cancer patients
Director of Bioinformatics and Head of Data Science, Cambridge, MA: Startup biotech expanding RNA for oncology
Director of In Vitro Pharmacology, Boston, MA: Mid-sized biotech growing AI drug discovery for oncology and neurodegeneration
Associate Director, Protein Engineering, Cambridge, MA: Mid-sized biotech developing genomic medicines
Associate Director, Immunology (Macrophage Cell Therapy), Cambridge, MA: Mid-sized biotech engineering cell therapies for multiple therapeutics areas
Associate Director, Watertown, MA: Small biopharmaceutical company focused on developing therapies for hematologic disorders
Associate Director, In Vivo Pharmacology, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Associate Director, Program Management, Watertown, MA: Small, Clinical-stage biopharma company developing RNA-modulating drugs to treat rare and ultra-rare diseases
Associate Director, Toxicology, Greater Boston, MA: Mid-sized clinical stage biopharma developing novel biologic treatments for rare diseases
Associate Director, Cell Therapy, Cambridge, MA: Mid-sized biotech pioneering cell therapies for intractable diseases
Associate Director, Watertown, MA: Small biopharmaceutical company focused on developing therapies for hematologic disorders
Associate Director of Translational Medicine, Boston, MA: Mid-sized biotech innovating therapies for Immunology, Oncology, and Metabolic diseases
Associate Director, Computational Biology, Cambridge, MA: Mid-sized biotech expanding cell and gene therapies for transformative results
Associate Director, Oncology, Boston, MA: Small biotech evolving RNA therapeutics for oncology and immunology
Associate Director, Immuno-Oncology, Boston, MA: Large biopharma expanding research and development for multiple therapeutic areas
Associate Director, Computational Biology, Cambridge, MA: Mid-sized biotech pioneering cell therapies for intractable diseases
Head of Target Biology, Cambridge, MA: Large biotech pioneering editing technology for serious diseases
Principal Scientist, Target Identification and Validation group, Cambridge, MA: Mid-sized biotech developing genomic medicines
Principal Scientist, Antibody Engineering, Greater Boston, MA: Mid-sized cell and gene therapy company dedicated to accelerating access to cutting-edge technologies and expertise
Principal Scientist, Structural Biology, Boston, MA: Mid-sized biotech focused in leveraging in vivo editing of the immune system and cell therapies to target diseases
Principal Scientist, Gene Editing, Cambridge, MA: Small biotech evolving nucleic acid therapeutics for oncology
Principal Scientist, In Vivo, Cambridge, MA: Mid-sized biotech expanding cell and gene therapies for transformative results
Principal Scientist, Biology (Neurobiology), Waltham, MA: Mid-sized R&D company with a focus on transforming disease treatment with small molecule therapeutics
Principal Scientist, Biochemistry, Greater Boston, MA: Mid-sized biologics based therapeutic company focused on genetic disease
Principal Scientist, Mass Spectrometry, Greater Boston, MA: Mid-sized CRO partner in the gene and cell therapy space
Principal Associate Scientist, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Associate Principal Scientist, Boston, MA: Startup biotech progressing ncRNA for immunology and oncology
Senior Scientist, Cambridge, MA: Small biotech evolving nucleic acid therapeutics for oncology
Senior Scientist, RNA Molecular Biology, Boston, MA: Startup biotech evolving RNA therapeutics for oncology and immunology
Senior Scientist, Cell Therapy, Cambridge, MA: Mid-sized biotech pioneering cell therapies for intractable diseases
Senior Scientist Cell Technologies, Cambridge, MA: Mid-sized biotech developing genomic medicines
Senior Scientist, Analytical Development, Lexington, MA: World’s leader in the search for a cure for people with cystic fibrosis
Senior Scientist, Regenerative Medicine, Cambridge, MA: Small biotech progressing molecular medicine for cutting edge therapeutics
Senior Scientist, Immunology, Greater Boston, MA: Mid-sized biologics based therapeutic company focused on genetic disease
Senior Scientist, Ocular Drug Discovery, San Francisco, CA: Mid-sized biotech enhancing precision medicines for oncology
Senior Scientist, Immunology, Watertown, MA: Mid-sized biotech developing mRNA-based therapies
Senior Scientist, Modeling, Boston, MA: Mid-sized biotech harnessing epigenetics for various therapeutic areas
Senior Scientist, Stem Cell Biology, Greater Boston, MA: Mid-sized cell and gene therapy company dedicated to accelerating access to cutting-edge technologies and expertise
Senior Scientist, Bioinformatics, Watertown, MA: Small biotech advancing immunotherapies for oncology and infectious diseases
Senior Scientist, Cambridge, MA: Mid-sized biotech expanding cell and gene therapies for transformative results
Senior Scientist I, Platform Biology, Watertown, MA: Mid-sized biotech developing mRNA-based therapies
Senior Scientist II, Protein Sciences, Greater Boston, MA: Mid-sized cell and gene therapy company dedicated to accelerating access to cutting-edge technologies and expertise
Senior Scientist, In Vivo Immunology, Lexington, MA: Small biopharma advancing novel molecules to treat disease
Senior Scientist, Cell Therapy, Boston, MA: Mid-sized biotech expanding drug condensates for various therapeutic areas
Senior Scientist, Comp Bio, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Senior Scientist, Cell Technologies, Waltham, MA: Mid-Sized biotech creating T Cell therapies for immunology
Senior Associate Scientist, In Vivo Pharmacology, Boston, MA: Small clinical-stage biopharma expanding immunotherapies for oncology
Scientist I, Gene Editing, Cambridge, MA: Stealth Mode startup biotech
Scientist I/II, Next Generation Sequencing, Cambridge, MA: Small biotech enhancing multiple modalities for Ocular diseases, CNS, and Immunology
Scientist II, Watertown, MA: Mid-sized biotech developing mRNA-based therapies
Scientist II, Stem Cell Biology, Woburn, MA: Small biotech advancing antibody therapeutics for severe diseases
Scientist II, Boston, MA: Mid-sized biotech developing drug condensates for various therapeutic areas
Scientist II, Bioanalytical Assay Development, Watertown, MA: Mid-sized biotech developing mRNA-based therapies
Scientist II, Development, Greater Boston, MA: Mid-sized cell and gene therapy company dedicated to accelerating access to cutting-edge technologies and expertise
Associate Scientist II, Stem Cell Biology, Greater Boston, MA: Mid-sized clinical stage biopharma developing novel biologic treatments for rare diseases
Associate Scientist II, Molecular/Viral Vector Biology, Greater Boston, MA: Mid-sized biotech developing cutting edge biologics for severe genetic diseases
Scientist, Viral Vector Engineering and Production, Cambridge, MA: Small biotech improving novel approaches for genetic disorders
Scientist, Bioinformatics, Greater Boston, MA: Mid-sized CRO partner in the gene and cell therapy space
Scientist, Cell Therapy, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Scientist, Translational Immunotherapy, Waltham, MA: Mid-sized R&D company with a focus on transforming disease treatment with small molecule therapeutics
Scientist, tRNA Biology, Cambridge, MA: Stealth Mode startup biotech
Scientist, Nucleic Acid Design, Greater Boston, MA: Small biotech advancing stem cell based cellular therapies
Associate Cell Culture Scientist, Boston, MA: Medium sized clinical-stage biotech focused in molecular approaches to medicine
Associate Scientist, Immunotherapy, Greater Boston, MA: Mid-sized cell and gene therapy company dedicated to accelerating access to cutting-edge technologies and expertise
Laboratory Operations Manager, Cambridge, MA: Small biotech lab advancing entrepreneurs and investors in the biotech community
Lab Manager, Lexington, MA: Small biopharma advancing novel molecules to treat disease
Lab Manager, Cambridge, MA: Mid-sized biotech developing genomic medicines
Program Leader, Ophthalmology, San Mateo, CA: Mid-sized clinical-stage biopharma advancing therapeutics for oncology and other serious diseases
Senior Manager, Flow Cytometry, Watertown, MA: Small, Clinical-stage biopharma company developing RNA-modulating drugs to treat rare and ultra-rare diseases
Group Leader, Target ID, Boston, MA: Mid-sized biotech developing drug condensates for various therapeutic areas
Group Leader, Target ID, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Investigator II, Natick, MA: Small TechBio improving isoforms for oligonucleotide therapies
Senior Computational Biologist, Cambridge, MA: Small biotech evolving nucleic acid therapeutics for oncology
Data Analyst, Waltham, MA: Mid-sized R&D company with a focus on transforming disease treatment with small molecule therapeutics
Senior Research Associate, Cambridge, MA: Small biotech progressing molecular medicine for cutting edge therapeutics
Senior Research Associate, Cell Pharmacology and Assay Development, Cambridge, MA: Mid-sized biotech pioneering cell therapies for intractable diseases
Senior Research Associate, San Mateo, CA: Mid-sized clinical-stage biopharma advancing therapeutics for oncology and other serious diseases
Senior Research Associate, Discovery Biology, Cambridge, MA: Biopharma expanding novel therapeutics for oncology
Senior Research Associate, In Vivo Pharmacology, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Research Associate, NGS, Boston, MA: Mid-sized biotech progressing cell and gene therapy for multiple diseases
Research Associate, Cellular Immunology, Cambridge, MA: Mid-sized biotech expanding cell and gene therapies for transformative results
Research Associate II, Pre-Clinical Programs, Greater Boston, MA: Mid-sized CRO partner in the gene and cell therapy space
Tox Study Coordinator, Greater Boston, MA: Mid-sized cell and gene therapy company dedicated to accelerating access to cutting-edge technologies and expertise

Contract

  • Computational Biologist, Data Sciences, Cambridge, MA, large biotech company working with cellular metabolism in rare diseases
  • Contractor, Biologist, Hematology, Cambridge, MA, large biotech company working with cellular metabolism in blood disorders
  • In Vivo Resources Associate, Pharmacology, Cambridge, MA, large biotech company working with cellular metabolism in blood disorders and rare diseases
  • Associate Scientist, NGS, Boston, MA, Rapidly growing startup developing unique molecular approach for Gene Therapy
  • Associate Scientist/Sr. Associate Scientist, Boston, MA, Rapidly growing startup using gene therapy for discovery and development
  • Principal Associate Scientist, Boston, MA, Rapidly growing startup developing molecules for Gene Therapy
  • Sr Clinical Scientist II (Associate Director), Cambridge, MA, Large biopharma company developing novel therapeutics in Epigenetics
  • Associate Scientist, Vector Production, Boston, MA, Midsized preclinical stage company developing next gen viral vector therapy for countless diseases
  • Associate Scientist II, Biology, Boston, MA, Midsized preclinical stage company using next gen viral vector therapy for countless diseases
  • Associate Scientist I, Immuno-Oncology, Boston, MA, Midsized company using next gen viral vector therapy for countless diseases
  • Chemistry Production Tech, Cambridge, MA, Small biotech developing peptide synthesis for Oncology
  • Senior Research Associate, Cell Biologist, Pre-Clinical NGS, Cambridge, MA, Large biotech using CRISPR for Various Cancers and Autoimmune Diseases
  • Research Associate, Analytical Development – Bioassay, Cambridge, MA, Large biotech developing gene therapy for genetic diseases
  • Research Associate Molecular Design and Delivery, Boston, MA, Small bio-innovation company using novel non-viral gene therapy
  • RA I/II, Molecular Assay Development/Analytical Development, Boston, MA, Small bio-innovation company developing novel non-viral gene therapy to treat broad range of diseases
  • Senior Research Associate, Boston, MA, Small biotech platform for protein based therapeutics in animal health
  • Research Associate, Boston, MA, Small startup biotech platform for protein based therapeutics in animal health
  • Scientific Consultant – Preclinical Team, Waltham, MA, Midsize biotech developing antibodies to protect from serious viral diseases
  • RA, Bioanalytical, Boston, MA, Midsized biotech developing synthetic biology and beneficial microbes to solve agricultural challenges
  • Research Associate/ Senior Research Associate, Cambridge, MA, Stealth mode startup developing oligonucleotide based therapies
  • Research Associate I,Lexington, MA, Clinical stage biopharma focused on novel treatments for hematological and musculoskeletal disorders
  • Research Associate II, Lexington, MA, Midsized clinical stage biopharma focused on novel treatments for hematological and musculoskeletal disorders
  • Research Associate I/II, In Vivo, Lexington, MA, Clinical stage biopharma focused on novel treatments for hematological and musculoskeletal disorders
  • Research Associate, Oligonucleotide Chemistry, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • (Sr.) Research Associate/Associate Scientist, Cell Biology, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA I, HTS, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA, Cell Biology, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • Research Associate, High-throughput Screening, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA, Platform Discovery, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • Associate Scientist, Oligonucleotide Manufacturing,Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • Research Associate, High-throughput Screening, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • Research Associate, Oligonucleotide Compound Management, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • Research Associate, Oligonucleotide Chemistry, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA I/II, In Vivo Pharmacology, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA I/II, HTS, Cambridge, MA, Midsized biotech developing precision medicine for rare genetic diseases
  • Senior Scientist II, Boston, MA, Commercial stage biopharma company developing antibody and protein technology redefining how cancer is treated
  • RA I- Molecular Technologies, Cambridge/Waltham, MA, Microbiome therapeutics platform company developing novel class
  • Operations Associate II/Sr. Associate          , Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Associate I, Analytical Operations, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Associate Scientist, Discovery Biology, Watertown, MA, Stealth company using next generation targeted delivery of biologics possible metabolic, muscle, neuro and immunological indications
  • Senior Research Associate, Cell and Molecular Biology, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • RA, Pharmacology, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Sr RA Human Therapeutics, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Sr Research Associate, Platform Engineering, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Sr Research Associate, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Sr Research Associate, Virus Production, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Research Associate, Discovery, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Research Associate, Chemistry, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Research Associate, Molecular Biology, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Senior Research Associate, Molecular Biology, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas

Clinical & Regulatory

Permanent

  • SVP Clinical Operations – Neuro, Needham, MA: Small-Mid sized biotech committed to providing a brighter future for patients suffering from neurological disorders
  • Chief Medical Officer, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology 
  • Vice President, Clinical Development – Rare Disease, Boston, MA:  Small growing clinical-stage biotech developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing
  • Vice President, Clinical Operations -Oncology, Watertown, MA: Small immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments
  • Chief Medical Officer – Rare Disease, Charlestown, MA: Small biotech focused on discovering small molecules that help restore CFTR protein
  • VP Clinical Development – Oncology, Cambridge, MA:  Mid-Sized biotech focused in precision therapy to create life-changing medicines for cancer and blood disorders
  • Chief Medical Officer – Neuro, Waltham, MA: Small, drug discovery and development company focused on revolutionizing disease treatment with small molecules
  • VP Clinical Development Operations, Cambridge, MA:  Small, early-stage Boston-area startup company working at the frontier of immuno-oncology
  • Senior Medical Director – CNS, Boston, MA: Mid-Sized biotech focused in RNA-targeted therapy
  • VP Clinical Development, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • VP Biometrics, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics
  • VP Biometrics – Oncology, Waltham, MA:  Small, clinical- stage biopharmaceutical company developing an innovative pipeline of cancer therapies
  • VP Clinical Operations – Cell Therapy, Cambridge, MA:  Small biotech pioneering a platform technology for donor-independent blood stem cell transplants
  • VP Clinical Development – Cardio, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics
  • VP Clinical Development – Oncology, Cambridge, MA:  Mid-Sized biotech focused in precision therapy to create life-changing medicines for cancer and blood disorders
  • VP Clinical Operations – Cell Therapy, Waltham, MA: Mid-Sized Biotech leading the development of innovative cell therapies, focused on restoring natural immunity in patients with severely compromised immune systems
  • VP Clinical Development Operations, Cambridge, MA:  Small, early-stage Boston-area startup company working at the frontier of immuno-oncology
  • VP Clinical Development ,Waltham, MA: Small, clinical-stage biopharma company focused in immune-oncology
  • VP Program Management – Cell Therapy, Boston, MA:  Small biotech advancing a pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis diseases
  • VP Clinical Development, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • VP Clinical Operations, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics
  • VP Program Management – Cell Therapy, Cambridge, MA:  Small biotech pioneering a platform technology for donor-independent blood stem cell transplants
  • VP Clinical Operations – CNS/Derm, Wellesley MA: Small biotech focused on developing treatments for dermatology products
  • VP Clinical Operations – Immuno-oncology, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • VP Clinical Operations – Neuro, Waltham, MA:  Small drug discovery and development company focused on revolutionizing disease treatment with small molecules
  • VP Clinical Operations, Rare Disease, Boston, MA:  Small, growing, clinical-stage biotech company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing
  • VP Regulatory Affairs, Boston, MA: Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • VP Regulatory and Quality – Rare Disease, Lexington, MA:  Medium-sized, clinical-stage biopharmaceutical company focused on the creating treatments for patients suffering from rare disorders
  • Chief Medical Officer – Rare Disease, Boston, MA: Small, clinical-stage biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing
  • Senior Medical Director – Neuro, Woburn, MA: Small, late-clinical stage biopharmaceutical company focused on creating therapies for patients suffering from serious gastrointestinal (GI) diseases
  • Senior Medical Director – Neurology, Needham, MA: Small-Mid Sized biotech committed to providing a brighter future for patients suffering from neurological disorders
  • Medical Director – Hematology, Lexington, MA:  Medium sized, clinical-stage biopharmaceutical company focused on the creating treatments for patients suffering from rare disorders
  • Medical Director, Microbiome, Boston, MA:  Small, clinical-stage biopharmaceutical company focused on harnessing the power of the human gut microbiome
  • Medical Director, Rare Disease, Boston, MA:  Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • Sr. Director Clinical Operations – Multiple Therapeutics, Cambridge, MA:  Large, clinical stage genome editing company working with CRISPR systems to develop treatments for serious diseases
  • Sr. Director Medical Communications – Rare Disease, Boston, MA:  Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • Sr. Director, Biostatistics, Boston, MA:  Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • Sr. Director, Clinical Operations, Cambridge, MA:  Small, clinical-stage development company with a portfolio focused on immune modulatory drugs for neurodegenerative disease
  • Sr. Director, Clinical Operations, Cambridge, MA:  Small Biotech with a strong foundation in immuno-oncology and translational cancer medicine, focused in molecules and biologics
  • Sr. Director, Clinical Operations, Boston, MA: Small biopharmaceutical company developing innovative treatments for resistant bacterial infections
  • Sr. Director, Clinical Operations – Gene Therapy, Cambridge, MA: Small, clinical-stage biotechnology company focused in retinal gene therapy
  • Sr. Director, Clinical Operations – Orphan Disease, Needham, MA: Small-Mid Sized biotech committed to providing a brighter future for patients suffering from neurological disorders
  • Sr. Director, Clinical Scientist – Oncology, Cambridge, MA: Large, clinical-stage genome editing company working with CRISPR systems to develop treatments for serious diseases
  • Sr. Director, Regulatory Affairs – Rare Disease, Cambridge, MA:  Small biopharmaceutical company specializing in developing drugs for the treatment of cancer
  • Sr. Director, Regulatory Affairs – Rare Disease, Boston, MA:  Small biotechnology company working on a treatment for patients with a specific genetic brain disorder
  • Senior Director, Regulatory Affairs – Rare Disease, Boston, MA:  Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • Senior Director, Field Based, Cambridge, MA: Medium sized biopharma company developing antibody and protein technology for oncology and autoimmune diseases
  • Executive Director, Trial Management – Neuroscience, Lexington, MA:  Medium-sized, clinical-stage biopharmaceutical company focused in creating treatments for patients suffering from rare disorders
  • Director Clinical Operations, Watertown, MA:  Mid Sized biotech dedicated to developing transformative medicines to restore the minds of people with serious brain disease
  • Director Clinical Operations, Cambridge, MA:  Small, clinical-stage biotech company leveraging stem cell biology and biotherapeutics to expand the accessibility of stem cell transplantation
  • Director Clinical Operations – Oncology, Cambridge, MA:  Large, innovative pharmaceutical company committed to developing future medicines for patients in therapeutic areas such as oncology, central nervous system, autoimmunity, and anti-infection
  • Director Data Management, Watertown, MA: Mid-Sized biopharma company pioneering innovative chemistry to discover and develop unique therapeutics to treat various disease
  • Director Data Management – Oncology, Cambridge, MA:  Small, clinical-stage biopharmaceutical company developing  therapeutics for cancer research.
  • Director Medical Affairs – Neuro, Needham, MA: Small-Mid Sized biotech committed to providing a brighter future for patients suffering from neurological disorders
  • Director – Medical Writing, Lexington, MA:  Medium sized, clinical-stage biopharmaceutical company focused in creating treatments for patients suffering from rare disorders
  • Director, Clinical Operations – I/O, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • Director, Clinical Operations – Oncology, Watertown, MA:  Mid-Sized biopharmaceutical company dedicated to first-in-class therapeutic candidates transforming the lives of patients with hematologic disorders
  • Director, Clinical Operations – Oncology, Woburn, MA: Small biotech dedicated to discovering and developing novel medicines that effectively address diseases emerging from respiratory distress.
  • Director, Clinical Outsourcing, Cambridge, MA: Small, clinical-stage biotechnology company focused in retinal gene therapy
  • Director, Clinical Pharmacology, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics
  • Director, Medical Writing, Cambridge, MA:  Mid-Sized biotech focused in innovative gene editing to discover and develop curative treatments for genetic diseases
  • Director, Patient Enrollment – Gene Therapy, Cambridge, MA:  Small, clinical-stage biotechnology company focused in retinal gene therapy
  • Director, Program Management – Oncology, Watertown, MA: Small immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments
  • Director, Regulatory Affairs, Lexington, MA: Large global biopharma with a focus on people living with infertility, multiple sclerosis and cancer
  • Director, Regulatory Affairs, Arlington, MA:  Small, clinical-stage biopharmaceutical company focused on developing therapies for severe and rare eye diseases
  • Director, Regulatory Affairs, Boston, MA:  Small biotechnology company working on a treatment for patients with a specific genetic brain disorder
  • Director, Regulatory CMC, Cambridge, MA: Large, clinical- stage genome editing company working with CRISPR systems to develop treatments for serious diseases
  • Director, Regulatory Operations – I/O, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • Director/AD Clinical Business Operations, Thousand Oaks, CA:  Small biotech pioneering a platform technology for donor-independent blood stem cell transplants
  • Director, Medical Writing, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics
  • Head of Biostats, Boston, MA: Small biotechnology company developing new drugs targeting brain metabolism
  • Head of Clinical Operations, Cambridge, MA: Small biotech that acquires and transforms innovative molecules into life-improving medicines across multiple therapeutic areas
  • Head of Clinical Operations, Boston, MA: Large global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases
  • Head of Regulatory Affairs – Oncology/Rare Disease, Burlington, MA: Publicly traded biopharmaceutical company focused on the discovery and development of therapies for cancer and other rare diseases
  • Head of Regulatory Affairs – Rare Disease, Cambridge, MA: Biotechnology company translating cutting edge technology for innovative treatments for patients with rare disorders
  • Senior Manager, PV, Boston, MA: Small-Mid sized biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare pathway diseases
  • AD Clinical Project Management – Hematology, Lexington, MA:  Medium sized, clinical-stage biopharmaceutical company focused on treatments for patients suffering from rare disorders
  • AD Clinical Scientist – Hem/Onc/Immunology, Waltham, MA:  Large biotech focused on developing antibody-drug conjugates
  • Associate Director, Clinical Operations, Cambridge, MA:  Large Biotech leading the way in groundbreaking research to develop health solutions for diseases in both humans and animals
  • Associate Director, Clinical Operations – Cell Therapy, Waltham, MA:  Mid Sized Biotech leading the development of innovative cell therapies, focused on restoring natural immunity in patients with severely compromised immune systems
  • Associate Director, Clinical Operations – Immunotherapy, Palo Alto, CA:  Small biotech focused in immunotherapy to develop and deliver transformative medicines for patients with cardiovascular disease
  • Associate Director, Clinical Operations – Rare Disease, Charlestown, MA: Small biotech focused on discovering small molecules that help restore CFTR protein
  • Associate Director, Clinical Operations – Rare Disease, Cambridge, MA:  Mid-Sized biotech company specializing in the discovery and development therapeutics for rare immune-mediated diseases
  • Associate Director, Medical Affairs, Boston, MA:  Small biopharmaceutical company, focused on discovering, developing, and commercializing small molecule drugs
  • Associate Director, Program Management, Waltham, MA: Mid-Sized Biotech leading in the development of innovative cell therapies, focused on restoring natural immunity in patients with severely compromised immune systems
  • Sr. Manager, Clinical Operations, Needham, MA:  Small development-stage biopharmaceutical company dedicated to creating and bringing to market medicines for cancer
  • Sr. Manager, Clinical Outsourcing, Waltham, MA:  Large biopharmaceutical company using proprietary kinase inhibitors and extensive knowledge in kinase biology to develop and commercialize innovative cancer medicine
  • Sr. Manager, Medical Writing, Cambridge, MA:  Large, clinical-stage genome editing company working with CRISPR systems to develop treatments for serious diseases
  • Sr. Manager, Medical Writing, Needham, MA: Small-Mid sized biotech committed to providing a brighter future for patients suffering from neurological disorders
  • Manager, Data Management, Waltham, MA:  Large biopharmaceutical company using proprietary kinase inhibitors and extensive knowledge in kinase biology to develop and commercialize innovative cancer medicine
  • Manager, TMF, Cambridge, MA: Small, clinical-stage biotechnology company focused in retinal gene therapy
  • Manager, Trail Master File- CNS, Boston, MA: Small, clinical-stage biopharmaceutical company focused on patients with diabetic neuropathy and Alzheimer’s disease
  • Principal Clinical Data Manager, Watertown, MA: Mid-Sized biopharma company pioneering innovative chemistry to discover and develop unique therapeutics to treat various disease
  • Principal Clinical Trial Lead, Lexington, MA: Large, global biopharma focused on people living with infertility, multiple sclerosis and cancer
  • Principal, Clinical Data Management, Watertown, MA: Mid-Sized biopharma company pioneering innovative chemistry to discover and develop unique therapeutics to treat various disease
  • Senior Clinical Data Manager, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • Senior Clinical Data Manager, Needham, MA:  Small, development-stage biopharmaceutical company dedicated to creating and bringing to market medicines for cancer
  • Senior Clinical Trial Manager, Waltham, MA: Large, oncology-focused biotech discovering candidates that modulate the function of the immune system
  • Senior CTM, Watertown, MA: Mid-Sized biopharma company pioneering innovative chemistry to discover and develop unique therapeutics to treat various disease
  • Clinical Operations Lead, Boston, MA:  Small, late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics
  • Clinical Operations Lead, Cambridge, MA:  Small biotech that acquires and transforms innovative molecules into life-improving medicines across multiple therapeutic areas
  • Clinical Project Manager, Watertown, MA: Mid-Sized biopharma company pioneering innovative chemistry to discover and develop unique therapeutics to treat various disease
  • Clinical Scientist – Hematology/Oncology, Waltham, MA:  Small, clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies
  • Clinical Trial Lead, Waltham, MA: Large, oncology-focused biotech discovering candidates that modulate the function of the immune system
  • Clinical Trial Manager, Boston, MA: Small biotech focused on translating innovative science to develop and deliver innovative therapies for cancer
  • Clinical Trial Manager – Oncology/I-O, Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology
  • Medical Science Liaison, Boston, MA: Midsized company developing gene therapy for countless diseases
  • Site Relationship and Operations Lead, Lexington, MA: Large, global biopharma that is focused on people living with infertility, multiple sclerosis and cancer
  • Sr. Clinical Project Manager, Boston, MA: Small, global biotech focusing on oral small molecule therapies for fibrosis, lysosomal storage disorders, and oncology
  • Sr. Clinical Project Manager – CNS, Diabetes, Pain, Boston, MA: Small, clinical-stage biopharmaceutical company focused on unmet needs in patients with diabetic neuropathy and Alzheimer’s disease
  • Sr. Clinical Trial Manager – Oncology Waltham, MA: Small, clinical-stage biopharma focused in immune-oncology

Contract

  • Manager of Clinical Data Management, Cambridge, MA, large biotech company working with cellular metabolism in rare diseases
  • Manager/Lead, Clinical Data Management, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Clinical Trial Associate, Los Angeles, CA, Biotech development novel medicines targeting metabolic and age-related diseases
  • Clinical Trial Manager, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Senior Clinical Trial Manager, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • Clinical Operations Manager, Cambridge, MA, Large biopharma company developing novel therapeutics in Epigentics
  • Clinical Sample Associate, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Trial Monitoring Manager, Cambridge, MA, Large biopharma company developing antibody and protein technology for Oncology
  • Pharmacovigilance Contractor, Waltham, MA, Large biotech developing Antibody-Drug Conjugates for Oncology
  • Sr Trial Master File Specialist, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • Trial Monitoring Manager, Boston, MA, Commercial stage biopharma company developing antibody and protein technology for oncology and autoimmune diseases
  • Clinical Sample Associate I, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Senior Manager CDM/Lead CDM, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Clinical Trial Manager, Auburndale, MA, Midsized innovative biotech bringing mitochondrial targeted therapies to treat common and rare diseases
  • Technical Writer, Waltham, MA, Large biotech developing Antibody-Drug Conjugates for anticancer therapeutics
  • Clinical Sample Associate – Biotech, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Sr Manager Medical Writing, Boston, MA, Large biopharma company developing antibody and protein technology for oncology and autoimmune diseases
  • Senior Clinical Trial Associate, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases

Technical Operations/CMC/Quality

Permanent

Vice President, CMC (Small Molecule), Waltham, MA: Small biotech developing novel therapies for precision oncology
Vice President, CMC (Biologics), Boston, MA: Medium sized clinical-stage gene editing focused biotech
Executive Director, External Manufacturing and Supply, Boston, MA: Mid-sized biotech focused on cardiovascular disease
Senior Director, GXP QA, Boston, MA: Small biotech focused on neurological disorders
Senior Director, Analytical Development, Cambridge, MA: Small clinical-stage biopharma developing novel therapeutics for oncology
Senior Director, Gene Therapy and Process Development, Cambridge, MA: Mid-sized clinical stage company focused on gene editing therapies
Senior Director, QA, Cambridge, MA: Small clinical-stage biotech developing antibody therapeutics for cancer
Director, AAV Process and Analytical Development, Cambridge, MA: Medium clinical stage biotech developing genetic based medicines
Director, External Quality Control, Boston, MA: Medium sized clinical-stage biotech focused in cutting edge molecular approaches to medicine
Director, Small Molecule Drug Substance, Waltham, MA: Small-Midsized biotech developing biologic therapies for oncology
Director, LNP Formulation, Watertown, MA: Mid-sized biotech developing mRNA-based therapies
Director, External Manufacturing Tech Ops, Boston, MA: Mid-sized biotech developing genetic based therapies
Director, CMC Analytical Development, Cambridge, MA: Mid-sized biotech developing genomic medicines
Director, Manufacturing Science & Technology, Cambridge, MA: Small biotech developing novel approaches for genetic disorders
Director, GMP Quality Operations, Greater Boston, MA: Mid-sized biotech developing cutting edge biologics for severe genetic diseases
Director, MSAT Drug Substance, Greater Boston, MA: Mid-sized clinical stage biopharma developing novel biologic treatments for rare diseases
Director, Head of RNA Production, Cambridge, MA: Small biotech developing molecular medicine for cutting edge therapeutics
Director, Head of Cell Therapy Process Development, Cambridge, MA: Small biotech developing manufacturing processes for cell therapy
Director, Antibody Process Development, Greater Boston, MA: Large biotech developing antibody therapeutics to treat oncology
Associate Director, Oligonucleotide Drug Substance Manufacturing, Greater Boston, MA: Mid-sized biologics based therapeutic company focused on genetic disease
Associate Director, Downstream Process Development (Biologics), Greater Boston, MA: Small biotech developing novel targeted biologics for oncology
Associate Director, Analytical Development, Greater Boston, MA: Small biotech developing novel therapeutics for neurological focused disease
Associate Director, QA Documentation & Training, Cambridge, MA: Small biotech developing antibody therapies treating oncology
Associate Director, Clinical Supply Chain, Cambridge, MA: Small clinical stage biotech developing novel therapeutics for oncology
Associate Director, Upstream Process Development, Greater Boston, MA: Small biotech developing antibody therapeutics focused on targeting cancers
Associate Director, GCP Clinical Quality Assurance, Greater Boston, MA: Small biotech developing small molecules for metabolic and cardiovascular
Associate Director, Protein Process Development, Cambridge, MA: Mid-sized biotech company developing gene editing for serious diseases
Principal Scientist, Cell Therapy Process Development, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Vice President, Technical Operations, Cambridge, MA: Medium sized clinical-stage oncology company developing targeted therapies
Vice President, CMC Manufacturing, Cambridge, MA: Small biopharmaceutical company specializing in orphan metabolic disease
Vice President, Program and Alliance Management, Cambridge, MA: Small clinical-stage biotech developing antibody therapeutics for cancer
Senior Director Quality Assurance, Cambridge, MA: Small biotech developing therapies for the treatment of cancer and other diseases
Senior Director, ADC Analytical Development, Cambridge, MA: Small biotech developing antibody therapies treating oncology
Senior Director, Biopharma Programs, Lexington, MA: World’s leader in the search for a cure for people with cystic fibrosis ( I feel like we should leave the wording as is here OK)
Director, Alliance & Program Management, Waltham, MA: Mid-sized R&D company with a focus on transforming disease treatment with small molecule therapeutics
Director, Alliance Management & Business Development, Boston, MA: Small, clinical-stage biopharma developing a proprietary platform to work with the body’s own immune system to fight disease
Director, Operations, Cambridge, MA: Mid-sized regenerative medicine company founded to develop therapies for Type 1 Diabetes
Director, Project Management, Watertown, MA: Mid-sized clinical-stage biopharma developing novel therapeutics for oncology and hematologic diseases
Director, Quality Assurance, Waltham, MA: Waltham, MA: Small biotech developing novel therapies for precision oncology
Associate Director, Analytical Development & QC, Cambridge, MA: Small, biotech developing manufacturing processes for cell therapy
Associate Director, Analytical Product Lead, Cambridge, MA: Small, clinical stage company developing immunotherapy treatments utilizing T cell therapies for cancer patients
Associate Director, Cell Analytical Development, Boston, MA: Small biotech creating immune cell therapies for treating patients with cancer and immune disorders
Associate Director, Drug Linker Analytics, Cambridge, MA: Small biotech developing antibody therapies treating oncology
Associate Director, QC Operations, Boston, MA: Clinical stage biotech working to improve treatments for patients with blood cancers
Associate Director, GMP Manufacturing, Cambridge, MA: Mid-sized regenerative medicine company founded to develop therapies for Type 1 Diabetes
Associate Director, Program Management, Watertown, MA: Small, Clinical-stage biopharma company developing RNA-modulating drugs to treat rare and ultra-rare diseases
Associate Director, Analytical Development, Boston, MA: Small biotech developing novel therapeutics for neurological focused disease
Associate Director, Analytical Development & Quality Control, Cambridge, MA: Small clinical stage biotech developing novel therapeutics for oncology
Associate Director, Cellular Process Development, Cambridge, MA: Medium clinical stage biotech developing genetic based medicines
Associate Director, Data Analytics, Cambridge, MA: Large global biotechnology company focused on developing precision genetic medicine for rare diseases
Associate Director, Downstream Process Development, Cambridge, MA: Small clinical-stage biotech developing antibody therapeutics for cancer
Associate Director, Process Engineering, Lexington, MA: Mid-sized regenerative medicine company focused on therapeutics that activate the body’s innate potential
Associate Director, Program Management, Greater Boston, MA: Mid-sized cell and gene therapy company dedicated to accelerating access to technologies and expertise
Associate Director, Quality Assurance, Waltham, MA: Small-Midsized biotech developing biologic therapies for oncology
Associate Director, Quality Operations, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Associate Director, Upstream Process Development, Cambridge, MA: Small clinical-stage biopharma developing novel therapeutics for oncology
Principal Associate Scientist, AD, Waltham, MA: Large biotech focused on development and manufacturing for multiple therapeutic areas
Scientist, Associate Director, Cell Therapy Process Development, Watertown, MA: Mid-sized biotech developing mRNA-based therapies
Senior Manager, QC Microbiology, Greater Boston, MA: Mid-sized cell and gene therapy company dedicated to accelerating access to technologies and expertise
Sr. Manager, Vector Production, Boston, MA: Preclinical stage biotech using next gen viral vector therapy
Sr. Manager, Process Engineering, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Sr. Manager, Quality Product Testing, Greater Boston, MA: Large biotechnology company developing targeted cancer therapeutics
Senior Manager, Upstream Process Development, Cambridge, MA: Small clinical stage biotech developing novel therapeutics for oncology
Sr. Manager, Supply Chain and Logistics, External Manufacturing, Boston, MA: Medium sized clinical-stage biotech focused in molecular approaches to medicine
Manager, Aseptic Manufacturing, Greater Boston, MA: Mid-sized biotech expanding cell and gene therapies
Manager, Manufacturing Cell Therapy, Greater Boston, MA: Mid-sized cell and gene therapy company dedicated to accelerating access to new technologies and expertise
Manager of Quality Systems, Greater Boston, MA: Mid-sized CRO partner in the gene and cell therapy space
Manager, Viral Vector Manufacturing, Cambridge, MA: Mid-sized biotech developing gene editing for serious diseases
Principal QA Specialist, Waltham, MA: Mid-sized clinical-stage biotech expanding therapies for antibody technologies
Principal Scientist, Scale Up Process Development, Greater Boston, MA: Small biotech advancing stem cell based cellular therapies
Principal Scientist, LNP Formulation, Cambridge, MA: Small biotech creating mRNA therapies to cure severe disease
Principal Scientist, Analytical Development, Greater Boston, MA: Small biotech working with stem cell based cellular therapies
Principal Scientist, QC Analytical Development, Cambridge, MA: Small, clinical stage company developing immunotherapy treatments utilizing T cell therapies for cancer patients
Senior/Principal Scientist, Drug Product Formulation, Cambridge, MA: Mid-sized pharmaceutical developing small molecules for gene expression
Senior Scientist, Analytical Research & Development, Cambridge, MA: Small biotech progressing molecular medicine for cutting edge therapeutics
Senior Scientist, Vector Process Development, Cambridge, MA: Small, clinical stage company developing immunotherapy treatments utilizing T cell therapies for cancer patients
Senior Scientist II, Analytical Development, Cell Therapy, Watertown, MA: Mid-sized biotech developing mRNA-based therapies
Sr. Scientist, Vector Upstream & Downstream, Greater Boston, MA: Mid-sized cell and gene therapy company dedicated to accelerating access to technologies and expertise
Sr. Scientist, Downstream Process Development, Cambridge, MA: Small biotech developing therapies for the treatment of cancer and other diseases
Sr. Scientist, Analytical Development, Greater Boston, MA: Mid-sized biotech expanding cell and gene therapies
Sr. Scientist, Process R&D, Cambridge, MA: Small biotech improving novel approaches for genetic disorders
Sr. Scientist, Downstream Vector Process Development, Greater Boston, MA: Mid-sized biotech progressing cell and gene therapies
Sr. Scientist, Nanoparticle DNA & RNA Drug Delivery, Watertown, MA: Mid-sized biotech developing mRNA-based therapies
Sr. Scientist, Cell Therapy Process Development, Waltham, MA: Mid-Sized biotech creating T Cell therapies for immunology
Scientist I, Cellular Analytical Development, Cambridge, MA: Medium clinical stage biotech developing genetic based medicines
Scientist II, CMC, Watertown, MA: Small biopharmaceutical company focused on developing therapies for hematologic disorders
Scientist II, Cell Therapy Process Development, Watertown, MA: Mid-sized biotech developing mRNA-based therapies
Scientist, Analytical Development, Boston, MA: Small biotech developing therapies with their gene delivery platform for cancer
Scientist, iPSC Cell Production, Greater Boston, MA: Large biotech enhancing treatments for oncology and cardiovascular diseases
Scientist, Nanoparticle DNA & RNA Drug Delivery, Watertown, MA: Mid-sized biotech developing mRNA-based therapies
Scientist, Drug Substance Process Development, Cambridge, MA: Small clinical-stage biotechnology company using mRNA to target disease
Scientist, Analytical & Formulation Development, Greater Boston, MA: Mid-sized biotech developing cutting edge biologics for severe genetic diseases
Sr. Associate Scientist, Upstream Process Development, Cambridge, MA: Small biotech developing therapies for the treatment of cancer and other diseases
Senior Associate Scientist, Process Development, Greater Boston, MA: Mid-sized biotech growing cell and gene therapies
In Vitro Pharmacologist, Cambridge, MA: Mid-sized regenerative medicine company founded to develop therapies for Type 1 Diabetes
Senior Engineer, MS&T, Waltham, MA: Mid-sized biotech developing novel cell therapies against deadly virus-associated diseases
Commissioning & Qualification Engineer II, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Process Engineer, Cambridge, MA: Mid-sized biotech developing gene editing for serious diseases
MES Solutions Architect, Greater Boston, MA: Mid-sized cell and gene therapy company dedicated to accelerating access to technologies and expertise
Vector Production Lead, Boston, MA: Mid-sized biotech focused in leveraging in vivo editing of the immune system and cell therapies to target diseases

Contract

  • Sr. RA, Compound Management, Cambridge, MA, Large biotech company working with cellular metabolism in rare diseases
  • Lab Manager, Process Development, South Boston, MA, Large gene editing company focused on transformative gene-based medicines
  • Contractor, Sample Inventory Management, South Boston, MA, Large gene editing company focused on transformative gene-based medicines
  • Lab Manager, Process Development, South Boston, MA, Large gene editing company focused on transformative gene-based medicines
  • Senior Specialist, Quality Systems and Compliance, Waltham, MA, Large biopharma company focused on kinase biology for Oncology
  • QA Documentation Contractor, Waltham, MA, Large biotech developing Antibody-Drug Conjugates for Oncology
  • Lab Assistant, Cambridge, MA, Large biotech using CRISPR for Various Cancers and Autoimmune Diseases
  • Associate Scientist, Production Core, Boston, MA, Small bio-innovation company using novel non-viral gene therapy
  • Lab Operations Associate, Boston, MA, Small bio-innovation company developing novel non-viral gene therapy to treat broad range of diseases
  • RA II, Bioassay Development/Analytical Development, Boston, MA, Small bio-innovation company using novel non-viral gene therapy
  • Scientific Consultant, Technical Operations Team, Waltham, MA, Midsized biotech transcending limits of naturally occurring immunity
  • Associate Scientist, DMPK, Cambridge, MA, Midsized biotech developing RNA editing for genetic diseases
  • RA I/II, In Vivo Pharmacology, Cambridge, MA, Midsized biotech developing precision medicine for rare genetic diseases
  • Lab Operations Associate, Cambridge, MA, Midsized biotech using fungi to produce drugs for intractable human diseases via novel biological mechanisms
  • Quality Assurance Contractor, Cambridge, MA, Clinical Stage biopharma company developing Antibody-Drug conjugates for Oncology
  • CMC Temp, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • R&D Program Management Consultant, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • Principal QA Specialist, Cambridge, MA, Clinical Stage biopharma company developing Antibody-Drug conjugates for Oncology
  • Lab Manager, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Director of Facilities, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Project Manager, Quality Control, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Analyst EM, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • GCP Audit Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Lab Support Associate, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Raw Materials Associate I, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Analyst I, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Manufacturing Associate I, Microbiome, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • CMC Project Manager, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Warehouse Supply Chain Associate I/II, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Analyst I – Environmental Monitoring, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Sr. Associate, Procurement, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QA Specialist II, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Analyst II – Raw Materials, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Manufacturing Associate, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QA Specialist II, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Facilities Associate – Biotech, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Manufacturing Associate – Microbiome Therapeutics, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Lab Operations Associate – Biotech, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC Analyst I – Environmental Monitoring, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Facilities Manager, Cambridge/Waltham, MA, Clinical stage company developing microbiome for chronic and inflammatory, infectious disease and oncology
  • External Quality Control Associate, Cambridge, MA, Midsized biotech company developing M T-Cell therapies for oncology
  • Senior Research Associate, Analytical Development Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
  • Senior Quality Control Specialist, Boston, MA, Large biotech company creating transformative medicines for serious diseases
  • Materials Management Specialist, Boston, MA, Large biotech company creating transformative medicines for serious diseases

General and Administrative/ Human Resources

  • TA Sourcing Partner, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology
  • TA Specialist, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology
  • TA Consultant, Waltham, MA, Biopharma company developing complement medicine for rare disease
  • TA Consultant, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology
  • Event Coordinator, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology
  • Event Planner – Pharma, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology
  • Contract Recruiter, Greater Boston, MA, Clinical stage biopharma company developing transformative medicines with small-molecule drugs
  • TA Coordinator, Watertown, MA, Small biotech developing novel therapies for transformative medicines
  • Document Specialist Contractor, South Boston, MA, Large gene editing company focused on transformative gene-based medicines
  • Contract Recruiter, Boston, MA, Midsized preclinical stage company developing next gen viral vector therapy for countless diseases
  • Senior Analyst- Strategic Finance, Boston, MA, Large biotech developing cell programming for multiple applications
  • Talent Acquisition Contractor, Waltham, MA, Large biotech developing Antibody-Drug Conjugates for Oncology
  • Project Administrator, Boston, MA, Small biotech platform for protein-based therapeutics in animal health
  • Contract Recruiter, Cambridge, MA, Clinical Stage biopharma company developing Antibody-Drug conjugates for Oncology
  • Talent Acquisition Contractor, Cambridge, MA, Clinical Stage biopharma company developing Antibody-Drug conjugates for Oncology
  • Accounts Payable Associate, Cambridge, MA, Clinical Stage biopharma company developing Antibody-Drug conjugates for Oncology
  • Manager, Patient Enrollment and Site Engagement, Cambridge, MA, Midsized biotech developing Antibody-Drug conjugates for Oncology
  • Administrative Assistant, Boston, MA, Large biopharma company developing antibody and protein technology for oncology and autoimmune diseases
  • Executive Administrative Assistant to the CSO, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Temp Executive Administrative Assistant, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Part-Time Nursing Consultant – Corporate Covid Policy, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Administrative Assistant – Donor Programs, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • TA Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • QC LMS Administrator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Audit Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Executive Assistant, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Compensation and Benefits Consultant, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Training and Documentation Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Audit Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Inspection Administrative Coordinator, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • AP Specialist, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Talent Management Consultant, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Talent Acquisition Coordinator – Biotech, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • IT Service Desk Engineer, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Office Manager, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Manager, People and Benefits Operations, Cambridge/Waltham, MA, Large biotech company developing microbiome for infectious diseases and inflammatory diseases
  • Quality Assurance Documentation and Training Specialist, Cambridge, MA, Clinical stage biotech developing immunotherapy co novel t cells for oncology
  • Document Control Coordinator, Boston, MA, Clinical stage biotech innovating cell therapy for oncology
  • Talent Operations Specialist, Waltham, MA, Biopharma company discovering novel treatments for Ophthalmology, Nephrology Hematology, and Neurology

Stratacuity Partners with Biologics Company To Grow Their First Scientific Team

“We don’t have to take the required time to screen hundreds of resumes; Stratacuity handles all of that, presents us with a few choice candidates, we have always found at least one if not more candidates (the first time it was 3 out of 4) to hire immediately and they have jumped in and helped us immensely.”
Learn More